Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-22-015086

President and CEO sold 42,460 shares at an average $32.51 ($1,380,380)

  • President and CEO acquired 42,460 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kinney Gene G. President and CEO 2022-08-04 Option exercise +20,954 $6.41 $134,315 33,747 D: show line 1 in the form
Kinney Gene G. President and CEO 2022-08-04 Sale −20,954 $32.18 $674,316 12,793 D: show line 2 in the form
Kinney Gene G. President and CEO 2022-08-05 Option exercise +21,506 $6.41 $137,853 34,299 D: show line 3 in the form
Kinney Gene G. President and CEO 2022-08-05 Sale −16,833 $32.77 $551,558 17,466 D: show line 4 in the form
Kinney Gene G. President and CEO 2022-08-05 Sale −4,673 $33.06 $154,505 12,793 D: show line 5 in the form
Open-market sales · 42,460 sh · avg $32.51 · $1,380,380

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kinney Gene G. President and CEO 2022-08-04 Option exercise · Stock Option (Right to Buy) −20,954 77,744 D: show line 6 in the form
Kinney Gene G. President and CEO 2022-08-05 Option exercise · Stock Option (Right to Buy) −21,506 56,238 D: show line 7 in the form
Loading xslF345X03/doc1.xml…